

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | activation of protein kinase A activity (GO:0034199) | 8.90270008 |
| 2 | cAMP biosynthetic process (GO:0006171) | 8.82977617 |
| 3 | DNA integration (GO:0015074) | 6.50680399 |
| 4 | replicative senescence (GO:0090399) | 6.50488630 |
| 5 | protein prenylation (GO:0018342) | 5.76961384 |
| 6 | prenylation (GO:0097354) | 5.76961384 |
| 7 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 5.69195356 |
| 8 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 5.63095667 |
| 9 | sulfation (GO:0051923) | 5.37385590 |
| 10 | DNA replication-dependent nucleosome assembly (GO:0006335) | 5.24423419 |
| 11 | DNA replication-dependent nucleosome organization (GO:0034723) | 5.24423419 |
| 12 | cAMP metabolic process (GO:0046058) | 4.93046095 |
| 13 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 4.68621756 |
| 14 | positive regulation of prostaglandin secretion (GO:0032308) | 4.60204455 |
| 15 | molting cycle (GO:0042303) | 4.53105334 |
| 16 | hair cycle (GO:0042633) | 4.53105334 |
| 17 | regulation of activation of Janus kinase activity (GO:0010533) | 4.51590325 |
| 18 | protein K11-linked deubiquitination (GO:0035871) | 4.51111918 |
| 19 | cyclic purine nucleotide metabolic process (GO:0052652) | 4.48855531 |
| 20 | hematopoietic stem cell proliferation (GO:0071425) | 4.48698624 |
| 21 | regulation of DNA damage checkpoint (GO:2000001) | 4.45955276 |
| 22 | cyclic nucleotide biosynthetic process (GO:0009190) | 4.43478176 |
| 23 | cellular response to ethanol (GO:0071361) | 4.39187107 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.36374491 |
| 25 | detection of molecule of bacterial origin (GO:0032490) | 4.36258980 |
| 26 | regulation of prostaglandin secretion (GO:0032306) | 4.29442853 |
| 27 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 4.28825866 |
| 28 | negative regulation of T-helper cell differentiation (GO:0045623) | 4.28697514 |
| 29 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 4.28697514 |
| 30 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.13049683 |
| 31 | post-anal tail morphogenesis (GO:0036342) | 4.08944965 |
| 32 | dendritic spine morphogenesis (GO:0060997) | 3.98289582 |
| 33 | viral mRNA export from host cell nucleus (GO:0046784) | 3.97028044 |
| 34 | growth hormone receptor signaling pathway (GO:0060396) | 3.85828828 |
| 35 | microglial cell activation (GO:0001774) | 3.80551165 |
| 36 | innate immune response in mucosa (GO:0002227) | 3.80101781 |
| 37 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.74135096 |
| 38 | righting reflex (GO:0060013) | 3.73558509 |
| 39 | positive regulation of RNA splicing (GO:0033120) | 3.71065724 |
| 40 | water transport (GO:0006833) | 3.70901301 |
| 41 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.57903377 |
| 42 | adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 3.54137702 |
| 43 | T cell mediated immunity (GO:0002456) | 3.53756459 |
| 44 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 3.50805972 |
| 45 | eosinophil chemotaxis (GO:0048245) | 3.48192685 |
| 46 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.47539033 |
| 47 | fluid transport (GO:0042044) | 3.46063087 |
| 48 | cellular response to growth hormone stimulus (GO:0071378) | 3.41779532 |
| 49 | regulation of endothelial cell differentiation (GO:0045601) | 3.32083648 |
| 50 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.26670800 |
| 51 | positive regulation by symbiont of host defense response (GO:0052509) | 3.23989034 |
| 52 | modulation by symbiont of host defense response (GO:0052031) | 3.23989034 |
| 53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.23989034 |
| 54 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.23989034 |
| 55 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.23989034 |
| 56 | modulation by symbiont of host immune response (GO:0052553) | 3.23989034 |
| 57 | mucosal immune response (GO:0002385) | 3.19123835 |
| 58 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 3.18654501 |
| 59 | cyclic nucleotide metabolic process (GO:0009187) | 3.18224399 |
| 60 | positive regulation of icosanoid secretion (GO:0032305) | 3.16218745 |
| 61 | negative regulation of catenin import into nucleus (GO:0035414) | 3.14901443 |
| 62 | tooth mineralization (GO:0034505) | 3.13178801 |
| 63 | eosinophil migration (GO:0072677) | 3.11193240 |
| 64 | spleen development (GO:0048536) | 3.06006470 |
| 65 | positive regulation of fatty acid transport (GO:2000193) | 3.01183299 |
| 66 | antibacterial humoral response (GO:0019731) | 3.00858514 |
| 67 | organ or tissue specific immune response (GO:0002251) | 2.97152153 |
| 68 | mammary gland alveolus development (GO:0060749) | 2.95137594 |
| 69 | retina layer formation (GO:0010842) | 2.94488086 |
| 70 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.93216556 |
| 71 | cellular response to glucagon stimulus (GO:0071377) | 2.93017838 |
| 72 | regulation of icosanoid secretion (GO:0032303) | 2.91280014 |
| 73 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.90278414 |
| 74 | nucleosome assembly (GO:0006334) | 2.86846572 |
| 75 | leukotriene biosynthetic process (GO:0019370) | 2.80326456 |
| 76 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.80154584 |
| 77 | antimicrobial humoral response (GO:0019730) | 2.77601991 |
| 78 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.75577809 |
| 79 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.74132275 |
| 80 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043) | 2.69780105 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.69156794 |
| 82 | neuronal action potential (GO:0019228) | 2.69085707 |
| 83 | macrophage activation involved in immune response (GO:0002281) | 2.66451511 |
| 84 | negative regulation of type 2 immune response (GO:0002829) | 2.62877224 |
| 85 | activation of phospholipase C activity (GO:0007202) | 2.59241592 |
| 86 | chemosensory behavior (GO:0007635) | 2.56224926 |
| 87 | regulation of skeletal muscle contraction (GO:0014819) | 2.55674810 |
| 88 | hepatocyte apoptotic process (GO:0097284) | 2.54534035 |
| 89 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.53502652 |
| 90 | prostate gland growth (GO:0060736) | 2.52697583 |
| 91 | detection of calcium ion (GO:0005513) | 2.51919008 |
| 92 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.50594158 |
| 93 | detection of chemical stimulus (GO:0009593) | 2.49345022 |
| 94 | macrophage activation (GO:0042116) | 2.47098447 |
| 95 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.45791587 |
| 96 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.44693928 |
| 97 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.43041984 |
| 98 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.43041984 |
| 99 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.40342581 |
| 100 | regulation of somitogenesis (GO:0014807) | 10.0169703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 7.06704447 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 5.48509571 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.03073358 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.87798315 |
| 5 | TP53_16413492_ChIP-PET_HCT116_Human | 2.32215126 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.28536100 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.26624719 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.19093254 |
| 9 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.06232007 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 13.7256643 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.99653375 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82815042 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77218807 |
| 14 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.67030387 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.64736241 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 1.56669699 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.47314197 |
| 18 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.42742922 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41336688 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.39887360 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37060516 |
| 22 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.32207689 |
| 23 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.27909040 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26125904 |
| 25 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.23422013 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22962900 |
| 27 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21128640 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20052232 |
| 29 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18089254 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15068296 |
| 31 | STAT3_23295773_ChIP-Seq_U87_Human | 1.14592549 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13577708 |
| 33 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09213742 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07397260 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06434762 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03633287 |
| 37 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.03197191 |
| 38 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01341346 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00945206 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.97488713 |
| 41 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94431579 |
| 42 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93557082 |
| 43 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93419142 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92600250 |
| 45 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92182089 |
| 46 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92138853 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 0.91988103 |
| 48 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91809169 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91379138 |
| 50 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.91264384 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89819670 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89794139 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89794139 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89149394 |
| 55 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88629618 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88629618 |
| 57 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88127596 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88041025 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.87971316 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87708043 |
| 61 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87624463 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.84917006 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84873141 |
| 64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83551898 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82035296 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.82021762 |
| 67 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80995714 |
| 68 | KDM2B_26808549_Chip-Seq_REH_Human | 0.80654515 |
| 69 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80484187 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79849117 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.79528986 |
| 72 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.78978862 |
| 73 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78503710 |
| 74 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.78205427 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77611476 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76816494 |
| 77 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.76279799 |
| 78 | AR_25329375_ChIP-Seq_VCAP_Human | 0.75462281 |
| 79 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.75161617 |
| 80 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.74946997 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.74825956 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74825956 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.74766552 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.74695974 |
| 85 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.74573385 |
| 86 | CJUN_26792858_Chip-Seq_BT549_Human | 0.73918229 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.73380171 |
| 88 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.72833651 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.72668724 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72468044 |
| 91 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.72409831 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.71980564 |
| 93 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.71033363 |
| 94 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.70395696 |
| 95 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.68580743 |
| 96 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.68405855 |
| 97 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.68377430 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.67677520 |
| 99 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.67519887 |
| 100 | EWS_26573619_Chip-Seq_HEK293_Human | 0.67266970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005084_abnormal_gallbladder_morpholo | 5.33209680 |
| 2 | MP0003183_abnormal_peptide_metabolism | 5.24812035 |
| 3 | MP0000569_abnormal_digit_pigmentation | 4.83754485 |
| 4 | MP0002163_abnormal_gland_morphology | 4.33453318 |
| 5 | MP0005379_endocrine/exocrine_gland_phen | 3.73459273 |
| 6 | MP0009764_decreased_sensitivity_to | 3.20891035 |
| 7 | MP0003252_abnormal_bile_duct | 3.00772697 |
| 8 | MP0002254_reproductive_system_inflammat | 2.98396195 |
| 9 | MP0005083_abnormal_biliary_tract | 2.89092965 |
| 10 | MP0002928_abnormal_bile_duct | 2.68157211 |
| 11 | MP0004130_abnormal_muscle_cell | 2.55366900 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.48927835 |
| 13 | MP0000371_diluted_coat_color | 2.48205745 |
| 14 | MP0008872_abnormal_physiological_respon | 2.09357838 |
| 15 | MP0003221_abnormal_cardiomyocyte_apopto | 1.99641239 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 1.96742005 |
| 17 | MP0004215_abnormal_myocardial_fiber | 1.89527965 |
| 18 | MP0002735_abnormal_chemical_nociception | 1.81813992 |
| 19 | MP0001800_abnormal_humoral_immune | 1.81019254 |
| 20 | MP0008961_abnormal_basal_metabolism | 1.76802789 |
| 21 | MP0002638_abnormal_pupillary_reflex | 1.71145254 |
| 22 | MP0005167_abnormal_blood-brain_barrier | 1.66741540 |
| 23 | MP0005220_abnormal_exocrine_pancreas | 1.60161291 |
| 24 | MP0004270_analgesia | 1.59119562 |
| 25 | MP0004484_altered_response_of | 1.57798025 |
| 26 | MP0002332_abnormal_exercise_endurance | 1.51671943 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.44710694 |
| 28 | MP0002090_abnormal_vision | 1.43243665 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.42128626 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.40762174 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.38654225 |
| 32 | MP0004510_myositis | 1.38307085 |
| 33 | MP0002160_abnormal_reproductive_system | 1.31125689 |
| 34 | MP0003195_calcinosis | 1.28543698 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.26169516 |
| 36 | MP0001177_atelectasis | 1.17343027 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.12634530 |
| 38 | MP0005451_abnormal_body_composition | 1.12231498 |
| 39 | MP0004134_abnormal_chest_morphology | 1.11651021 |
| 40 | MP0005389_reproductive_system_phenotype | 1.11612639 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.08911892 |
| 42 | MP0002723_abnormal_immune_serum | 1.08784681 |
| 43 | MP0003303_peritoneal_inflammation | 1.02639610 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.02221076 |
| 45 | MP0002419_abnormal_innate_immunity | 1.01557661 |
| 46 | MP0003633_abnormal_nervous_system | 1.01373642 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.00622497 |
| 48 | MP0009046_muscle_twitch | 1.00257709 |
| 49 | MP0003880_abnormal_central_pattern | 1.00011582 |
| 50 | MP0000613_abnormal_salivary_gland | 0.99149139 |
| 51 | MP0001819_abnormal_immune_cell | 0.98499894 |
| 52 | MP0005671_abnormal_response_to | 0.97304625 |
| 53 | MP0000685_abnormal_immune_system | 0.95791042 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 0.95215073 |
| 55 | MP0006072_abnormal_retinal_apoptosis | 0.91628557 |
| 56 | MP0005253_abnormal_eye_physiology | 0.91209772 |
| 57 | MP0003693_abnormal_embryo_hatching | 0.91155336 |
| 58 | MP0002075_abnormal_coat/hair_pigmentati | 0.89673049 |
| 59 | MP0000750_abnormal_muscle_regeneration | 0.82802545 |
| 60 | MP0003646_muscle_fatigue | 0.80533597 |
| 61 | MP0000716_abnormal_immune_system | 0.75183553 |
| 62 | MP0002095_abnormal_skin_pigmentation | 0.75057986 |
| 63 | MP0002932_abnormal_joint_morphology | 0.74833004 |
| 64 | MP0001270_distended_abdomen | 0.74365218 |
| 65 | MP0009785_altered_susceptibility_to | 0.74351483 |
| 66 | MP0005266_abnormal_metabolism | 0.73953583 |
| 67 | MP0001790_abnormal_immune_system | 0.73097920 |
| 68 | MP0005387_immune_system_phenotype | 0.73097920 |
| 69 | MP0003724_increased_susceptibility_to | 0.71877917 |
| 70 | MP0000163_abnormal_cartilage_morphology | 0.71532007 |
| 71 | MP0000749_muscle_degeneration | 0.71411751 |
| 72 | MP0002405_respiratory_system_inflammati | 0.71074306 |
| 73 | MP0003011_delayed_dark_adaptation | 0.69887133 |
| 74 | MP0005408_hypopigmentation | 0.69317454 |
| 75 | MP0000631_abnormal_neuroendocrine_gland | 0.68943177 |
| 76 | MP0003631_nervous_system_phenotype | 0.68532587 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.67793404 |
| 78 | MP0001919_abnormal_reproductive_system | 0.67122024 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.67087661 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.66949857 |
| 81 | MP0005166_decreased_susceptibility_to | 0.65899818 |
| 82 | MP0001845_abnormal_inflammatory_respons | 0.65552131 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 0.64175827 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.62228382 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.61540977 |
| 86 | MP0002398_abnormal_bone_marrow | 0.58675735 |
| 87 | MP0004133_heterotaxia | 0.58516426 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 0.58300574 |
| 89 | MP0002133_abnormal_respiratory_system | 0.57228951 |
| 90 | MP0005388_respiratory_system_phenotype | 0.57228951 |
| 91 | MP0005171_absent_coat_pigmentation | 0.56783374 |
| 92 | MP0003300_gastrointestinal_ulcer | 0.54549604 |
| 93 | MP0003690_abnormal_glial_cell | 0.54457150 |
| 94 | MP0003866_abnormal_defecation | 0.53754973 |
| 95 | MP0002272_abnormal_nervous_system | 0.53458884 |
| 96 | MP0002127_abnormal_cardiovascular_syste | 0.53357888 |
| 97 | MP0002722_abnormal_immune_system | 0.53215773 |
| 98 | MP0002006_tumorigenesis | 0.52541910 |
| 99 | MP0000609_abnormal_liver_physiology | 0.51139106 |
| 100 | MP0004885_abnormal_endolymph | 0.50842999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Anomalous pulmonary venous return (HP:0010772) | 8.69826908 |
| 2 | Abnormality of the pulmonary veins (HP:0011718) | 7.64404998 |
| 3 | Hemiplegia (HP:0002301) | 5.96163884 |
| 4 | Deformed sella turcica (HP:0002681) | 5.26803203 |
| 5 | Neoplasm of the heart (HP:0100544) | 4.73220248 |
| 6 | Slow saccadic eye movements (HP:0000514) | 4.37454011 |
| 7 | Tongue fasciculations (HP:0001308) | 4.27701414 |
| 8 | Muscle fibrillation (HP:0010546) | 4.10451880 |
| 9 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 4.07789972 |
| 10 | Short 4th metacarpal (HP:0010044) | 4.07789972 |
| 11 | Abnormality of the odontoid process (HP:0003310) | 4.02346659 |
| 12 | Abnormality of the sella turcica (HP:0002679) | 3.74662715 |
| 13 | Premature graying of hair (HP:0002216) | 3.64879875 |
| 14 | Rough bone trabeculation (HP:0100670) | 3.58047533 |
| 15 | Vertebral fusion (HP:0002948) | 3.38829675 |
| 16 | Pathologic fracture (HP:0002756) | 3.33699062 |
| 17 | Amelogenesis imperfecta (HP:0000705) | 3.30488312 |
| 18 | Diastasis recti (HP:0001540) | 3.29530189 |
| 19 | Carpal bone hypoplasia (HP:0001498) | 3.20618568 |
| 20 | Medulloblastoma (HP:0002885) | 3.17365646 |
| 21 | Short femoral neck (HP:0100864) | 3.10863664 |
| 22 | Hemivertebrae (HP:0002937) | 3.10089656 |
| 23 | Myelomeningocele (HP:0002475) | 3.09728214 |
| 24 | Short phalanx of the thumb (HP:0009660) | 3.00704012 |
| 25 | Abnormality of the 4th metacarpal (HP:0010012) | 2.91857076 |
| 26 | Down-sloping shoulders (HP:0200021) | 2.91088143 |
| 27 | Broad ribs (HP:0000885) | 2.90236627 |
| 28 | Abnormality of the intervertebral disk (HP:0005108) | 2.84100489 |
| 29 | J-shaped sella turcica (HP:0002680) | 2.78000760 |
| 30 | Abnormality of the renal collecting system (HP:0004742) | 2.70016695 |
| 31 | Thoracolumbar scoliosis (HP:0002944) | 2.68838266 |
| 32 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.64623644 |
| 33 | Abnormal trabecular bone morphology (HP:0100671) | 2.63653399 |
| 34 | Vertebral arch anomaly (HP:0008438) | 2.60043121 |
| 35 | Prominent occiput (HP:0000269) | 2.56047710 |
| 36 | Abnormality of the lumbar spine (HP:0100712) | 2.51519212 |
| 37 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.48421946 |
| 38 | Abnormality of the parietal bone (HP:0002696) | 2.47799598 |
| 39 | Impaired smooth pursuit (HP:0007772) | 2.46390845 |
| 40 | Genetic anticipation (HP:0003743) | 2.44454339 |
| 41 | Calf muscle hypertrophy (HP:0008981) | 2.43047668 |
| 42 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.38073802 |
| 43 | Milia (HP:0001056) | 2.35573570 |
| 44 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.33971568 |
| 45 | Skin pits (HP:0100276) | 2.23532661 |
| 46 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.17284252 |
| 47 | Concave nail (HP:0001598) | 2.16543728 |
| 48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.12648749 |
| 49 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.10273954 |
| 50 | Sparse lateral eyebrow (HP:0005338) | 2.09983375 |
| 51 | Flat acetabular roof (HP:0003180) | 2.08468676 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06729206 |
| 53 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06729206 |
| 54 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06729206 |
| 55 | Abnormality of nail color (HP:0100643) | 2.05136410 |
| 56 | Insidious onset (HP:0003587) | 2.04108363 |
| 57 | Termporal pattern (HP:0011008) | 2.04108363 |
| 58 | Oral leukoplakia (HP:0002745) | 10.6079794 |
| 59 | Cellular immunodeficiency (HP:0005374) | 1.97054811 |
| 60 | Meningocele (HP:0002435) | 1.96648688 |
| 61 | Hamartoma (HP:0010566) | 1.96241635 |
| 62 | Aortic regurgitation (HP:0001659) | 1.92891491 |
| 63 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92427078 |
| 64 | Hyporeflexia of lower limbs (HP:0002600) | 1.90578152 |
| 65 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.90519687 |
| 66 | Osteomalacia (HP:0002749) | 1.89456319 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 1.89290463 |
| 68 | Oligodontia (HP:0000677) | 1.89001490 |
| 69 | Duplicated collecting system (HP:0000081) | 1.88506564 |
| 70 | Neoplasm of the oral cavity (HP:0100649) | 1.87887379 |
| 71 | Neoplasm of striated muscle (HP:0009728) | 1.87516824 |
| 72 | Overgrowth (HP:0001548) | 1.87286752 |
| 73 | Abnormality of the pons (HP:0007361) | 1.85780049 |
| 74 | Flared iliac wings (HP:0002869) | 1.84527820 |
| 75 | Recurrent bronchitis (HP:0002837) | 1.82928737 |
| 76 | Bone marrow hypocellularity (HP:0005528) | 1.82807404 |
| 77 | Drooling (HP:0002307) | 1.81662432 |
| 78 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.80167133 |
| 79 | Hamartoma of the eye (HP:0010568) | 1.79808897 |
| 80 | Generalized hypopigmentation of hair (HP:0011358) | 1.75511375 |
| 81 | Conjunctival hamartoma (HP:0100780) | 1.74746454 |
| 82 | Beaking of vertebral bodies (HP:0004568) | 1.71964942 |
| 83 | Stenosis of the external auditory canal (HP:0000402) | 1.69925233 |
| 84 | Abnormality of renal resorption (HP:0011038) | 1.68441650 |
| 85 | Increased serum ferritin (HP:0003281) | 1.67795017 |
| 86 | Dyschromatopsia (HP:0007641) | 1.66616080 |
| 87 | Excessive salivation (HP:0003781) | 1.65335708 |
| 88 | Thoracic kyphosis (HP:0002942) | 1.62137621 |
| 89 | Death in childhood (HP:0003819) | 1.61521838 |
| 90 | Autoimmune hemolytic anemia (HP:0001890) | 1.61416208 |
| 91 | Cerebellar dysplasia (HP:0007033) | 1.59762451 |
| 92 | Cavernous hemangioma (HP:0001048) | 1.58401647 |
| 93 | Action tremor (HP:0002345) | 1.58333465 |
| 94 | Aseptic necrosis (HP:0010885) | 1.57488652 |
| 95 | Severe global developmental delay (HP:0011344) | 1.55197888 |
| 96 | Alveolar cell carcinoma (HP:0006519) | 1.53430986 |
| 97 | Hypoplasia of the pons (HP:0012110) | 1.52989382 |
| 98 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.49666641 |
| 99 | Broad alveolar ridges (HP:0000187) | 1.48885019 |
| 100 | Abnormality of iron homeostasis (HP:0011031) | 1.47106161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 9.80952948 |
| 2 | TLK1 | 5.22358237 |
| 3 | ZAK | 4.93812192 |
| 4 | MAP3K4 | 3.64672885 |
| 5 | MAP2K7 | 3.39717638 |
| 6 | MAP2K4 | 2.63878136 |
| 7 | IRAK3 | 2.62711326 |
| 8 | VRK1 | 2.25418685 |
| 9 | STK24 | 1.92707849 |
| 10 | CAMKK2 | 1.77195204 |
| 11 | STK4 | 1.65190516 |
| 12 | NTRK2 | 1.61963941 |
| 13 | STK38L | 1.60025824 |
| 14 | FRK | 1.53022165 |
| 15 | CAMK4 | 1.46672166 |
| 16 | RPS6KA5 | 1.35865492 |
| 17 | SYK | 1.35284441 |
| 18 | CAMK1D | 1.29995083 |
| 19 | SCYL2 | 1.26034442 |
| 20 | NEK9 | 1.22984730 |
| 21 | PIM1 | 1.01114868 |
| 22 | MAP3K2 | 0.97472853 |
| 23 | STK3 | 0.97203376 |
| 24 | PKN1 | 0.94649316 |
| 25 | ACVR1B | 0.93288294 |
| 26 | DAPK3 | 0.86919706 |
| 27 | BMPR2 | 0.86739112 |
| 28 | MAP3K5 | 0.85407278 |
| 29 | INSRR | 0.84544346 |
| 30 | SGK2 | 0.79852107 |
| 31 | RET | 0.79166999 |
| 32 | MAP4K1 | 0.77656278 |
| 33 | TAOK3 | 0.72231034 |
| 34 | CSK | 0.71994029 |
| 35 | LYN | 0.71164063 |
| 36 | TGFBR2 | 0.70301719 |
| 37 | CAMK1G | 0.67693399 |
| 38 | JAK2 | 0.66825557 |
| 39 | EIF2AK3 | 0.64832016 |
| 40 | GRK7 | 0.63919553 |
| 41 | ADRBK2 | 0.63284482 |
| 42 | IRAK4 | 0.61383921 |
| 43 | TAF1 | 0.56305338 |
| 44 | BRSK2 | 0.55117633 |
| 45 | IKBKE | 0.53997265 |
| 46 | GRK1 | 0.53945431 |
| 47 | PINK1 | 0.52222410 |
| 48 | CAMKK1 | 0.50487008 |
| 49 | OBSCN | 0.48744541 |
| 50 | CASK | 0.48314616 |
| 51 | SGK3 | 0.48144382 |
| 52 | RIPK4 | 0.47656653 |
| 53 | GRK6 | 0.47206447 |
| 54 | ERBB2 | 0.44212819 |
| 55 | PKN2 | 0.43758073 |
| 56 | MAP3K6 | 0.42510760 |
| 57 | TNIK | 0.42428671 |
| 58 | PIK3CG | 0.40873578 |
| 59 | PRKAA1 | 0.40860587 |
| 60 | BMPR1B | 0.40059987 |
| 61 | NTRK3 | 0.38286193 |
| 62 | EPHA3 | 0.38218616 |
| 63 | SGK223 | 0.37444111 |
| 64 | SGK494 | 0.37444111 |
| 65 | KSR2 | 0.36727037 |
| 66 | NEK6 | 0.36288503 |
| 67 | MAP3K12 | 0.34795584 |
| 68 | TXK | 0.32318154 |
| 69 | PRKCI | 0.31095366 |
| 70 | IKBKB | 0.30831806 |
| 71 | HIPK2 | 0.29816007 |
| 72 | IRAK1 | 0.29484547 |
| 73 | PDK1 | 0.29094183 |
| 74 | HCK | 0.28679291 |
| 75 | MAP3K8 | 0.28598790 |
| 76 | AURKA | 0.28339267 |
| 77 | GRK5 | 0.27666096 |
| 78 | MELK | 0.25079711 |
| 79 | SGK1 | 0.24406372 |
| 80 | MAP4K2 | 0.24362122 |
| 81 | MAPK4 | 0.24050537 |
| 82 | MATK | 0.23594910 |
| 83 | JAK1 | 0.21632950 |
| 84 | ADRBK1 | 0.21526077 |
| 85 | MAP2K3 | 0.21380232 |
| 86 | PAK3 | 0.21171195 |
| 87 | TEC | 0.19922660 |
| 88 | EGFR | 0.19030249 |
| 89 | PTK2B | 0.18950873 |
| 90 | MAP3K1 | 0.18413638 |
| 91 | CCNB1 | 0.18091451 |
| 92 | PRKAA2 | 0.17580393 |
| 93 | FYN | 0.17398322 |
| 94 | FGFR3 | 0.17350375 |
| 95 | STK11 | 0.17316541 |
| 96 | CSNK1A1L | 0.17130597 |
| 97 | MOS | 0.16975698 |
| 98 | MAP3K9 | 0.16883475 |
| 99 | PLK2 | 0.16246651 |
| 100 | AKT2 | 0.15557410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 7.35791687 |
| 2 | Alcoholism_Homo sapiens_hsa05034 | 4.86466798 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.52708190 |
| 4 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 2.24826873 |
| 5 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 2.20060152 |
| 6 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.95150421 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.90573718 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81765886 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 1.73937754 |
| 10 | Platelet activation_Homo sapiens_hsa04611 | 1.71459515 |
| 11 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.71223753 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65037680 |
| 13 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.59179264 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.59149456 |
| 15 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.50484264 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.41970304 |
| 17 | Bile secretion_Homo sapiens_hsa04976 | 1.41740302 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.41422100 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.36567617 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.35976409 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.34725154 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.34291840 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.31807992 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.26211932 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26071417 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.24320728 |
| 27 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.22251333 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.21784470 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.21696265 |
| 30 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.21153960 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.19143833 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.17126134 |
| 33 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15951221 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.13014710 |
| 35 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.12186997 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08912454 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.01611739 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99615039 |
| 39 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99000871 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98780066 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98269807 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 0.95125620 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92671669 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92587728 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90683517 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.88306733 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87919867 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.87455205 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86998500 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86799147 |
| 51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86386196 |
| 52 | Taste transduction_Homo sapiens_hsa04742 | 0.81495537 |
| 53 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.80229821 |
| 54 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79311065 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78201424 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78188535 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.78101361 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71659621 |
| 59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70329746 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70068808 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68475454 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67172678 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.65954453 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65364786 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65167229 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63523149 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62041582 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57678262 |
| 69 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.54463794 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54274305 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53566110 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50623106 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49464107 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48223552 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.47072743 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46427875 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45347158 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44831956 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44397346 |
| 80 | Nicotine addiction_Homo sapiens_hsa05033 | 0.43557068 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42887905 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41653966 |
| 83 | Influenza A_Homo sapiens_hsa05164 | 0.40289945 |
| 84 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39524944 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.39465293 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37997225 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37780967 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36060161 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33500680 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33272563 |
| 91 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29347013 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29193966 |
| 93 | Melanoma_Homo sapiens_hsa05218 | 0.26900612 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26599313 |
| 95 | Long-term potentiation_Homo sapiens_hsa04720 | 0.26552498 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26311461 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25417436 |
| 98 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.24949925 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.24803140 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23074609 |

